SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-Nov-24 9:50 PM View: | Natera, Inc. (NTRA) | 15-Nov-24 | Option Exercise | 37,230 | $23.48 | $874,177.00 | 236% 15.81K to 53.04K | |
15-Nov-24 9:50 PM View: | Natera, Inc. (NTRA) | 15-Nov-24 | Planned Option Sale | 37,230 | $146.11 | $5,439,560.00 | (70%) 53.04K to 15.81K | |
30-Jul-24 9:05 PM View: | Natera, Inc. (NTRA) | 26-Jul-24 | Grant | 143 | -- | -- | < 1% 15.54K to 15.68K | |
02-Jul-24 9:05 PM View: | Natera, Inc. (NTRA) | 28-Jun-24 | Grant | 2,964 | -- | -- | 24% 12.58K to 15.54K | |
10-May-24 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-24 | Grant | 6,500 | -- | -- | 27% 24.5K to 31.0K | |
30-Apr-24 8:35 PM View: | Natera, Inc. (NTRA) | 26-Apr-24 | Grant | 169 | -- | -- | 1% 12.41K to 12.58K | |
30-Jan-24 8:05 PM View: | Natera, Inc. (NTRA) | 26-Jan-24 | Grant | 215 | $63.79 | $13,714.90 | 2% 12.19K to 12.41K | |
31-Oct-23 9:05 PM View: | Natera, Inc. (NTRA) | 27-Oct-23 | Grant | 322 | $42.60 | $13,717.20 | 3% 11.87K to 12.19K | |
01-Aug-23 9:05 PM View: | Natera, Inc. (NTRA) | 28-Jul-23 | Grant | 264 | $48.48 | $12,798.70 | 2% 11.61K to 11.87K | |
05-Jul-23 10:00 PM View: | Natera, Inc. (NTRA) | 30-Jun-23 | Grant | 2,750 | -- | -- | 31% 8.86K to 11.61K | |
26-May-23 9:05 PM View: | Natera, Inc. (NTRA) | 25-May-23 | Option Exercise | 3,534 | -- | -- | 66% 5.32K to 8.86K | |
19-May-23 4:06 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-23 | Grant | 4,500 | -- | -- | 22% 20.0K to 24.5K | |
18-Apr-23 8:10 PM View: | Natera, Inc. (NTRA) | 14-Apr-23 | Grant | 228 | $54.73 | $12,478.40 | 4% 5.09K to 5.32K | |
18-Jan-23 9:35 PM View: | Natera, Inc. (NTRA) | 13-Jan-23 | Grant | 312 | $40.01 | $12,483.10 | 7% 4.78K to 5.09K | |
18-Oct-22 9:05 PM View: | Natera, Inc. (NTRA) | 14-Oct-22 | Grant | 275 | $45.42 | $12,490.50 | 6% 4.51K to 4.78K | |
27-Jun-22 4:48 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 23-Jun-22 | Grant | 20,500 | -- | -- | 89% 23.0K to 43.5K | |
27-May-22 9:45 PM View: | Natera, Inc. (NTRA) | 25-May-22 | Option Exercise | 1,307 | -- | -- | 46% 2.86K to 4.16K | |
12-May-22 8:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Grant | 3,000 | -- | -- | 18% 17.0K to 20.0K | |
09-Jun-21 7:03 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 08-Jun-21 | Grant | 11,000 | -- | -- | 92% 12.0K to 23.0K | |
02-Jun-21 7:58 PM View: | Natera, Inc. (NTRA) | 28-May-21 | Option Exercise | 2,856 | -- | -- | 100% 0 to 2.86K | |
18-May-21 9:25 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-21 | Grant | 3,000 | -- | -- | 21% 14.0K to 17.0K | |
11-Aug-20 6:20 PM View: | Natera, Inc. (NTRA) | 07-Aug-20 | Option Exercise | 1,300 | $24.42 | $31,746.00 | 100% 0 to 1.3K | 3% |
11-Aug-20 6:20 PM View: | Natera, Inc. (NTRA) | 07-Aug-20 | Market Option Sale | 1,300 | $53.47 | $69,513.00 | (100%) 1.3K to 0 | (103%) |
17-Jun-20 5:43 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Jun-20 | Grant | 8,000 | -- | -- | 200% 4.0K to 12.0K | |
19-May-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-20 | Grant | 3,000 | -- | -- | 27% 11.0K to 14.0K | |
01-Jul-19 4:58 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 27-Jun-19 | Grant | 4,000 | -- | -- | 100% 0 to 4.0K | |
10-May-19 8:33 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-19 | Grant | 2,000 | -- | -- | 22% 9.0K to 11.0K | |
11-May-18 9:10 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-18 | Grant | 2,500 | -- | -- | 38% 6.5K to 9.0K | |
18-May-17 6:18 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-17 | Grant | 2,500 | -- | -- | 62% 4.0K to 6.5K | |
26-Jul-16 1:47 PM View: | Travere Therapeutics, Inc. (TVTX) | 19-Jul-16 | Grant | 4,000 | -- | -- | 100% 0 to 4.0K |